Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

35.94
Delayed Data
As of Aug 16
 +0.31 / +0.87%
Today’s Change
35.04
Today|||52-Week Range
85.83
-27.86%
Year-to-Date

Today’s Trading

Previous close35.63
Today’s open35.89
Day’s range35.25 - 36.32
Volume2,510,212
Average volume (3 months)2,359,905
Market cap$3.5B
Dividend yield--
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+1.01%
P/E ratio19.6
Price/Sales2.30
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-0.11-0.15%
OPKOPKO Health Inc-0.03-0.49%
SAGESAGE Therapeutics In...-0.48-0.57%
PTLAPortola Pharmaceutic...-0.31-0.56%
Data as of 08/16/2017

Financials

Last reporting dateAugust 8, 2017
EPS forecast (this quarter)$1.73
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts